Relación entre vulnerabilidad social y evolución del filtrado glomerular en pacientes con enfermedad renal poliquística
| datacite.rights | http://purl.org/coar/access_right/c_f1cf | |
| dc.contributor.advisor | Aroca Martínez, Gustavo | |
| dc.contributor.advisor | Guido Musso, Carlos | |
| dc.contributor.author | Dulce Muñoz, Jaime Arturo | |
| dc.date.accessioned | 2026-02-10T19:22:09Z | |
| dc.date.available | 2026-02-10T19:22:09Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | La enfermedad renal poliquística (ERP) es la nefropatía hereditaria más frecuente y una causa relevante de enfermedad renal crónica. Su evolución clínica es heterogénea y, aunque tradicionalmente se explica por factores genéticos y clínicos, existe creciente interés en el papel de los determinantes sociales de la salud. La vulnerabilidad social podría influir indirectamente en la progresión renal a través de barreras de acceso, adherencia y continuidad del cuidado, especialmente en contextos de alta desigualdad como el Caribe colombiano. Objetivo: Determinar la relación entre la vulnerabilidad social y la evolución del filtrado glomerular en pacientes con enfermedad renal poliquística atendidos en un centro de referencia del Caribe colombiano durante el periodo 2008–2025. | spa |
| dc.description.abstract | Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disorder and a major cause of chronic kidney disease. Its clinical course is highly heterogeneous and has traditionally been explained by genetic and clinical factors. However, increasing attention has been given to the role of social determinants of health. Social vulnerability may indirectly influence renal progression through barriers to access, treatment adherence, and continuity of care, particularly in regions with marked social inequality such as the Colombian Caribbean. Objective: To determine the relationship between social vulnerability and the evolution of glomerular filtration rate in patients with autosomal dominant polycystic kidney disease treated at a referral center in the Colombian Caribbean between 2008 and 2025. | eng |
| dc.format.mimetype | ||
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/17347 | |
| dc.language.iso | spa | |
| dc.publisher | Ediciones Universidad Simón Bolívar | spa |
| dc.publisher | Facultad de Ciencias de la Salud. | spa |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | eng |
| dc.rights.accessrights | info:eu-repo/semantics/embargoedAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject | Enfermedad renal poliquística | spa |
| dc.subject | Vulnerabilidad social | spa |
| dc.subject | Filtrado glomerular | spa |
| dc.subject | Determinantes sociales de la salud | spa |
| dc.subject | Enfermedad renal crónica | spa |
| dc.subject.keywords | Autosomal dominant polycystic kidney disease | eng |
| dc.subject.keywords | Social vulnerability | eng |
| dc.subject.keywords | Glomerular filtration rate | eng |
| dc.subject.keywords | Social determinants of health | eng |
| dc.subject.keywords | Chronic kidney disease | eng |
| dc.title | Relación entre vulnerabilidad social y evolución del filtrado glomerular en pacientes con enfermedad renal poliquística | spa |
| dc.type.driver | info:eu-repo/semantics/other | |
| dc.type.spa | Otros | |
| dcterms.references | Authors S. Autosomal Dominant Polycystic Kidney Disease [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532934/ | eng |
| dcterms.references | Park J. Health disparities in kidney failure among patients with autosomal dominant polycystic kidney disease. Kidney Med. 2022;4(9):100502. | eng |
| dcterms.references | Irazabal M V, Rangel LJ, Bergstralh EJ. Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. J Am Soc Nephrol. 2015;26(1):160–72. | eng |
| dcterms.references | Irazabal M V, Rangel LJ, Bergstralh EJ. Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. J Am Soc Nephrol. 2015;26(1):160–72. | eng |
| dcterms.references | Norton JM. Social determinants of racial disparities in chronic kidney disease. J Am Soc Nephrol. 2016;27(9):2576–95. | eng |
| dcterms.references | Al-Chalabi S. Association of deprivation and its individual domains on outcomes in people with chronic kidney disease. Clin Kidney J. 2024;17(7):sfae086. | eng |
| dcterms.references | Gabbai FB. Area deprivation and risk of death and chronic kidney disease progression in patients under nephrology care. Nephron. 2020;144(10):488– 98. | eng |
| dcterms.references | Li Y. Residential neighborhood disadvantage and access to kidney transplantation in the United States. JAMA Netw Open. 2025;8(1):e2450123. | eng |
| dcterms.references | Norris K, Beech B. Social Determinants of Kidney Health: Focus on Poverty. Clin J Am Soc Nephrol. 2021;16(5):809–11. | eng |
| dcterms.references | Chebib FT, Torres VE. Recent advances in the management of autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2018;13(11):1765–76. | eng |
| dcterms.references | Colbert G, Elrggal M, Gaur L, Lerma E. Update and review of adult polycystic kidney disease. Disease-a-Month [Internet]. 2020;66(5):100887. Available from: https://doi.org/10.1016/j.disamonth.2019.100887 | eng |
| dcterms.references | Ars E, Bernis C, Fraga G, Furlano M, Martínez V, Martins J, et al. Documento de consenso de poliquistosis renal autosómica dominante del grupo de trabajo de enfermedades hereditarias de la Sociedad Española de Nefrología. Revisión 2020. Nefrología. 2022;42(4):367–89. | spa |
| dcterms.references | Wilson P. Polycystic Kidney Disease. N Engl J Med. 2004;350(2):151–64. | eng |
| dcterms.references | Pirson Y. Extrarenal Manifestations of Autosomal Dominant Polycystic Kidney Disease. Adv Chronic Kidney Dis [Internet]. 2010;17(2):173–80. Available from: http://dx.doi.org/10.1053/j.ackd.2010.01.003 | eng |
| dcterms.references | Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet [Internet]. 2019;393(10174):919–35. Available from: http://dx.doi.org/10.1016/S0140-6736(18)32782-X | eng |
| dcterms.references | Xue C, Zhou C-C, Wu M, Mei C-L. The Clinical Manifestation and Management of Autosomal Dominant Polycystic Kidney Disease in China. Kidney Dis. 2016;2(3):111–9. | eng |
| dcterms.references | Helal I. Review Article Autosomal Dominant Polycystic Kidney Disease : New Insights into Treatment of Kidney Diseases and Transplantation. Saudi J Kidney Dis Transplant. 2013;24(2):230–4. | eng |
| dcterms.references | Willey CJ, Blais JD, Hall AK, Krasa HB, Makin AJ, Czerwiec FS. Prevalence of autosomal dominant polycystic kidney disease in the European Union. Nephrol Dial Transplant. 2017;32(8):1356–63. | eng |
| dcterms.references | Guatibonza YP, Rodríguez RE, Córdoba JP, Zarante I. Actualidad de la enfermedad renal poliquística. Univ Médica. 2012;54(1):53–68. | eng |
| dcterms.references | Camargo JT, González CA, Herrera L, Yomayusa-González N, Ibañez M, Valbuena-García AM, et al. Autosomal dominant polycystic kidney disease in Colombia. BMC Nephrol. 2023;24(1):1–6. | eng |
| dcterms.references | Musso CG, Ricardo AC, Aroca-Martinez G, Chaparro M. Chronic Kidney Disease (CKD) classification for low-resource settings: Taking into account patients’ social vulnerability. Rev Colomb Nefrol. 2024;11(3):1–8. | eng |
| dcterms.references | Harris PC, Torres VE. Polycystic Kidney Disease , Autosomal Dominant Summary [Internet]. Adam M, Everman D, editors. Gene Reviews. Seattle: National Center for Biotechnology Information; 2022. 1–44 p. Available from: https://www.dropbox.com/s/v69ld7wp3fubw1r/Bookshelf_NBK1246.pdf?dl=0 | eng |
| dcterms.references | Montaña A, Patiño N, Larrate C, Zambrano FA, Martínez J, Lozano H, et al. Update on polycystic kidney disease. Rev Fac Med. 2018;66(1):107–16. | eng |
| dcterms.references | Willey C, Gauthier-Loiselle M, Cloutier M, Shi S, Maitland J, Stellhorn R, et al. Regional variations in prevalence and severity of autosomal dominant polycystic kidney disease in the United States. Curr Med Res Opin. 2021;37(7):1155–62. | eng |
| dcterms.references | Ulasi I, Awobusuyi O, Nayak S, Ramachandran R, Musso C, Depine S. Chronic Kidney Disease Burden in Low-Resource Settings: Regional Perspectives. Semin Nephrol. 2022;42(151336). | eng |
| dcterms.references | Menezes LF, Germino GG. Systems biology of polycystic kidney disease. J Am Soc Nephrol. 2009;20(6):1193–203. | eng |
| dcterms.references | Torres VE, Harris PC. Mechanisms of disease: autosomal dominant and recessive polycystic kidney diseases. Nat Rev Nephrol. 2009;5(7):372–82. | eng |
| dcterms.references | Heyer CM. Predicted mutation strength of PKD1 correlates with severity of renal disease. J Am Soc Nephrol. 2016;27(9):2872–84. | eng |
| dcterms.references | Grantham JJ. Polycystic kidney disease: neoplasia in disguise. Am J Kidney Dis. 1990;15(2):110–6. | eng |
| dcterms.references | Grantham JJ. Volume progression in polycystic kidney disease. N Engl J Med. 2006;354(20):2122–30. | eng |
| dcterms.references | Higashihara E. Long-term progression of autosomal dominant polycystic kidney disease. Clin Exp Nephrol. 2012;16(4):622–8. | eng |
| dcterms.references | Nowak KL. Overweight and obesity are predictors of progression in early ADPKD. J Am Soc Nephrol. 2018;29(2):571–8. | eng |
| dcterms.references | Crews DC. Socioeconomic factors and kidney disease. Semin Nephrol. 2013;33(4):371–9. | eng |
| dcterms.references | Cavanaugh KL. Health literacy in patients with chronic kidney disease. Semin Dial. 2011;24(5):534–8. | eng |
| dcterms.references | Nicholas SB. Socioeconomic disparities in chronic kidney disease. Adv Chronic Kidney Dis. 2015;22(1):6–15. | eng |
| dcterms.references | Patzer RE. Influence of race, ethnicity and socioeconomic status on kidney disease. Nat Rev Nephrol. 2012;8(9):533–41. | eng |
| dcterms.references | Garg PP. Income-based disparities in outcomes for patients with ESRD. J Am Soc Nephrol. 2001;12(12):2624–33. | eng |
| dcterms.references | Chapman AB, Devuyst O, Eckardt KU. Autosomal-dominant polycystic kidney disease: executive summary from a KDIGO Controversies Conference. Kidney Int. 2015;88(1):17–27. | eng |
| dcterms.references | Rossetti S, Kubly VJ, Consugar MB. Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation. J Am Soc Nephrol. 2009;20(2):409–16. | eng |
| dcterms.references | Cornec-Le Gall E, Audrezet MP, Le Meur Y. Genotype–phenotype correlation in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2013;24(6):1006–13. | eng |
| dcterms.references | Vart P, Gansevoort RT, Joosten H. Socioeconomic disparities in chronic kidney disease: a systematic review. Nephrol Dial Transpl. 2015;30(4):657– 66. | eng |
| dcterms.references | Bruce MA, Beech BM, Sims M. Social environmental stressors, psychological factors, and kidney disease. J Am Soc Nephrol. 2009;20(4):914–22. | eng |
| dcterms.references | Grubbs V, Plantinga LC, Tuot DS. Chronic kidney disease and neighborhood poverty in the United States. Clin J Am Soc Nephrol. 2014;9(12):2137–43. | eng |
| dcterms.references | Helal I, Reed B, McFann K. Racial differences in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2012;23(2):314–23. | eng |
| dcterms.references | Belmonte Serrano MÁ. Requisitos éticos en los proyectos de investigación. Otra oveja negra. Semin la Fund Esp Reumatol. 2010;11(1):7–13. | spa |
| dcterms.references | Eckardt K-U, others. Pathophysiology of renal anemia. Nephrol Dial Transplant. 2015;30(3):441–7. | eng |
| dcterms.references | Vaziri ND. Disorders of lipid metabolism in chronic kidney disease. J Ren Nutr. 2014;24(1):73–6. | eng |
| dcterms.references | Tonelli M, Wanner C. Dyslipidemia and chronic kidney disease. Kidney Int Suppl. 2011;1(3):19–25. | eng |
| dcterms.references | Stauffer ME, Fan T. Prevalence of anemia in chronic kidney disease in the United States. PLoS One. 2014;9(1):e84943. | eng |
| oaire.version | info:eu-repo/semantics/acceptedVersion | |
| sb.programa | Especialización en Nefrología | spa |
| sb.sede | Sede Barranquilla | spa |
Archivos
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 2.93 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción: